Home » BioCryst Initiates Phase II Study of Gout Drug
BioCryst Initiates Phase II Study of Gout Drug
BioCryst Pharmaceuticals, Inc. announced that it is initiating a Phase II study of BCX4208 for the treatment of gout.
TradingMarkets
TradingMarkets
Upcoming Events
-
07May
-
14May
-
30May